Resistance to anticancer drugs permanently alters electrophoretic mobility of cancer cell lines

被引:4
|
作者
Kazan, Hasan Hueseyin [1 ]
Urfali-Mamatoglu, Cagri [1 ]
Guenduez, Ufuk [1 ]
机构
[1] Middle East Tech Univ, Dept Biol Sci, Univ Mahallesi,Dumlupinar Blv 1, TR-06800 Ankara, Turkey
关键词
Cellular physicochemistry; Cellular morphology; Drug resistance; Electrophoretic mobility; HUMAN-BLOOD PLATELETS; HUMAN-ERYTHROCYTES; LEUKEMIC-CELLS; SOFT PARTICLES; SURFACE-CHARGE; IN-VITRO; NANOPARTICLES; SUSPENSIONS; SEPARATION; ADHESION;
D O I
10.1002/elps.201600494
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Electrophoretic mobility is a physical phenomenon defining the mobility of charged particles in a solution under applied electric field. As charged biological systems, living cells including both prokaryotes and eukaryotes have been assessed in terms of electrophoretic mobility to decipher their electrochemical structure. Moreover, determination of electrophoretic mobility of living cancer cells have promoted the advance exploration of the nature of the cancer cells and separation of cancer cells from normal ones under applied electric field. However, electrophoretic mobility of drug-resistant cells has not yet been examined. In the present study, we determined the electrophoretic mobility of drug-resistant cancer cell lines for both suspension and adherent cells and compared with those of drug-sensitive counterparts. We showed that resistance to anticancer drugs alters the electrophoretic mobility in a permanent manner, even lasting without any exposure to anticancer agents for a long time period. We also studied the cellular morphologies of adherent cells where the cellular invaginations and protrusions were increased in drug-resistant adherent cells, which could be direct cause of altered surface charge and electrophoretic mobility as a result. These findings could be helpful in terms of understanding the electrophysiological and physicochemical background of drug resistance in cancer cells and developing systems to separate drug-sensitive cells from drug-resistant ones.
引用
收藏
页码:1201 / 1205
页数:5
相关论文
共 50 条
  • [1] Extensive genetic and transcriptional variation alters the response of cancer cell lines to anticancer drugs.
    Ben-David, U.
    Siranosian, B.
    Ha, G.
    Tang, H.
    Thorner, A.
    Bittker, J.
    Beroukhim, R.
    Golub, T. R.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [2] Impact of Breast Cancer Resistance Protein Expression on the In Vitro Efficacy of Anticancer Drugs in Pancreatic Cancer Cell Lines
    Washio, Ikumi
    Nakanishi, Takeo
    Ishiguro, Naoki
    Yamamura, Norio
    Tamai, Ikumi
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (03) : 214 - 222
  • [3] Correlation between expression of oncogene products and resistance to anticancer drugs in cultured ovarian cancer cell lines
    Yoshiaki Okuma
    Kazushige Kiguchi
    Yutaka Koshitaka
    Asami Okamura
    Isamu Ishiwata
    Haruhiro Kondo
    Bunpei Ishizuka
    Mamoru Tadokoro
    Human Cell, 2003, 16 (3) : 131 - 139
  • [4] Role of ribophorin II in the response to anticancer drugs in gastric cancer cell lines
    Yuan, Tein-Ming
    Liang, Ruei-Yue
    Chueh, Pin Ju
    Chuang, Show-Mei
    ONCOLOGY LETTERS, 2015, 9 (04) : 1861 - 1868
  • [5] Nitric Oxide Synthase Potentiates the Resistance of Cancer Cell Lines to Anticancer Chemotherapeutics
    Barnawi, Ibrahim
    Hawsawi, Yousef M.
    Dash, Philip
    Oyouni, Atif Abdulwahab A.
    Mustafa, Syed Khalid
    Hussien, Nahed A.
    Al-Amer, Osama
    Alomar, Suliman
    Mansour, Lamjed
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (07) : 1397 - 1406
  • [6] ANTICANCER DRUGS Uncoupling resistance to cancer immunotherapy
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (03) : 171 - 171
  • [7] Current anticancer drugs differentially impact Black and White prostate cancer cell lines
    Badal, Simone
    Hwang, Bor-Jang
    Nelson, Ashlianne
    Frank, Kristoff
    Thompson, Rory
    Morison, Belinda
    Marah, Valerie
    Ragin, Camille
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [8] ENHANCEMENT OF SUPEROXIDE-DISMUTASE ACTIVITY IN CANCER CELL-LINES BY ANTICANCER DRUGS
    GOGUN, Y
    SAKURADA, S
    KIMURA, Y
    NAGUMO, M
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 1990, 8 (02) : 85 - 92
  • [9] Increased ALDH7A1 expression enhances the resistance to the anticancer drugs and colony formation in lung cancer cell lines
    Sakamori, Yuichi
    Ozasa, Hiroaki
    Kunii, Eiji
    Yagi, Yoshitaka
    Tsuji, Takahiro
    Nomizo, Takeshi
    Nagai, Hiroki
    Kim, Young Hak
    Maeno, Ken
    Oguri, Tetsuya
    Mishima, Michiaki
    CANCER RESEARCH, 2016, 76
  • [10] Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations
    Györffy, B
    Surowiak, P
    Kiesslich, O
    Denkert, C
    Schäfer, R
    Dietel, M
    Lage, H
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (07) : 1699 - 1712